NI
ABBV icon

NDVR Inc’s AbbVie ABBV Stock Holding History

NDVR Inc’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$521K Sell
2,279
-112
-5% -$25.5K 0.43% 24
2025
Q3 		$554K Sell
2,391
-44
-2% -$8.96K 0.46% 22
2025
Q2 		$452K Buy
2,435
+83
+4% +$15.4K 0.42% 26
2025
Q1 		$493K Sell
2,352
-108
-4% -$21K 0.5% 20
2024
Q4 		$437K Buy
2,460
+169
+7% +$31.1K 0.42% 25
2024
Q3 		$446K Sell
2,291
-21
-0.9% -$3.92K 0.46% 22
2024
Q2 		$397K Sell
2,312
-74
-3% -$12.3K 0.41% 23
2024
Q1 		$434K Buy
2,386
+245
+11% +$42.2K 0.41% 19
2023
Q4 		$332K Buy
+2,141
New +$312K 0.4% 22

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

NDVR Inc's ABBV Position: Q4 2025 in Review

NDVR Inc reduced its AbbVie (ABBV) stake by 4.7% in Q4 2025, selling an estimated $25.5K and leaving 2,279 shares worth $521K. The position accounts for 0.43% of the portfolio, ranked #24.

NDVR Inc first reported a position in ABBV in Q4 2023 and has held it in 9 quarters since. The position peaked at $554K in Q3 2025. 4,160 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

  • NDVR Inc held 2,279 shares of AbbVie worth $521K as of Q4 2025.
  • NDVR Inc sold 112 AbbVie shares in Q4 2025, an estimated $25.5K.
  • AbbVie made up 0.43% of NDVR Inc's portfolio in Q4 2025, its #24 holding.
  • NDVR Inc first reported a position in AbbVie in Q4 2023 and has held it in 9 quarters since.
  • NDVR Inc's AbbVie position peaked at $554K in Q3 2025.
  • 4,160 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on NDVR Inc's 13F filing for Q4 2025, filed 12 Feb 2026.